"Neuromodulation will be the go-to-it reference work for this rapidly expanding and fascinating field. The editors have assembled an all-star group of contributors who comprehensively cover all aspects of neuromodulation in the treatment of human disease and dysfunction."
—John D. Loeser, M.D., Departments of Neurological Surgery and Anesthesiology, University of Washington, Seattle, USA
"The greater than 40 year history of scientific inquiry into the interface between neural tissue and therapeutic electrical fields or targeted drug infusion has resulted in a body of rapidly growing evidence for positive effects when these technologies are applied to selected patients who suffer from chronic neurological diseases. The editors of Neuromodulation have organized a definitive knowledge resource for this growing and complex field by assembling many of the world leaders in basic neuroscience, electrical engineering and drug infusion technologies, and clinical investigation. Any new paradigm in medicine, such as neuromodulation, deserves such an outstanding text to help the clinician and researcher to navigate through novel concepts, clinical outcomes and promising new applications."
—Richard E. Kuntz, M.D., M.Sc., Sr. Vice President and President, Medtronic Neuromodulation, Minneapolis, USA
"As it has become possible to directly interact with neural tissue, neuromodulation as a new and very promising field of therapeutic approaches has emerged on a very steep path of development. Since the first applications to the treatment of pain with electrical stimulation numerous newly developed methods, including direct electrical stimulation and drug infusion, targeting neural tissue from the cortex to the basal ganglia, spinal cord, and peripheral nerves have made it possible to develop new very powerful therapeutic approaches to serious clinical conditions. Every new branch soon produces its own ramifications and the neuromodulation looks like a very fast-growing tree. This timely publication provides a global and comprehensive review of the current state of the art technology from new and exciting perspectives. This book will be a milestone in the development of neuromodulation."
—Alim Louis Benabid, Member Institut Universitaire de France, French Academy of Sciences, French Academy of Medicine, Royal Academy of Medicine of Belgium, Professor Emeritus of Biophysics at the Joseph Fourier University in Grenoble, Scientific Advisor at French Atomic Energy Commission, Grenoble, France
"Neuromodulation therapy has advanced dramatically in recent years and promises to grow into a multi-indication modality that will help millions who suffer from chronic pain and other – neurological diseases.…As, the awareness, acceptance, and use of Neuromodulation technologies grow, the thoughtful publication and updating of reference books like Neuromodulation will play a vital role in the sharing of knowledge and best practices, enabling the modality to reach its full clinical potential.…This book draws from the giants of Neuromodulation who have contributed greatly to the field’s expansion. It broadly captures the wisdom of many talented and caring people and shares it with the world. We will use this book and its future updates as a core resource to further strengthen our educational programs. I thank the editors and authors for their vision and ambitious efforts in making this important book a reality."
—Christopher G. Chavez, President, Neuromodulation Division, St. Jude Medical, St. Paul, USA
"Scientific progress is accelerated when ground breaking developments are put into context for the next generation to explore. The editors of Neuromodulation have assembled a foundation of evidence that will spur the curious minds of scientists, clinicians, researchers and industry. This document will lead to new discoveries that reinforce the spirit of innovation and challenge our current beliefs. Congratulations to the authors and editors on assembling a reference for the ages."
—Michael Onuscheck, Senior Vice President and President of Neuromodulation, Boston Scientific Corporation, Boston, USA
|
|